Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1381-1387

  Saario, Susanna M ^a   Savinainen, Juha R ^a   Laitinen, Jarmo T ^a   Järvinen, Tomi ^a   Niemi, Riku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

2 AG; 2 arachidonoylglycerol; AA 5 HT; AEA; AM404; Arachidonoyl serotonin; Arachidonoyl trifluoromethylketone; ATFMK; Bovine serum albumin; BSA; BTNP; N (4 hydroxyphenyl) arachidonylamide; N arachidonoylethanolamide

Indexed keywords

1 ARACHIDONOYLGLYCEROL; 2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONOYLSEROTONIN; ARACHIDONYL TRIFLUOROMETHYL KETONE; BENZYLSULFONYL FLUORIDE; CANNABINOID; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ETHANOLAMINE DERIVATIVE; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; FLUORIDE; HEXADECYLSULFONYLFLUORIDE; HYDROLASE INHIBITOR; METHYLARACHIDONYLFLUOROPHOSHONATE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N ARACHIDONOYLETHANOLAMIDE; OL 53; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; HYDROLYSIS; IC 50; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CELL MEMBRANE; CEREBELLUM; GLYCERIDES; HYDROLYSIS; MALE; MONOACYLGLYCEROL LIPASES; RATS; RATS, WISTAR;

EID: 1542346866     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.12.003     Document Type: Article

References (50)

1. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
2. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R.et al. Identification of an endogenous 2-monoglyceride present in canine gut that binds to cannabinoid receptors. Biochem. Pharmacol. 50:1995;83-90.
3. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys Res. Commun. 215:1995;89-97.
4. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
5. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274:1999;2794-2801.
6. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., Hipkin R.W. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57:2000;1045-1050.
7. Savinainen J.R., Jarvinen T., Laine K., Laitinen J.T. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134:2001;664-672.
8. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275:2000;605-612.
9. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
10. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport as revealed by selective inhibition. Science. 277:1997;1094-1097.
11. Hillard C.J., Edgemond W.S., Jarrahian A., Campbell W.B. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69:1997;631-638.
12. Schmid P.C., Zuzarte-Augustin M.L., Schmid H.H. Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 260:1985;14145-14149.
13. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide a cannabinoid receptor agonist. Biochem. Pharmacol. 46:1993;791-796.
14. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:1996;83-87.
15. Glaser S.T., Abumrad N.A., Fatade F., Kaczocha M., Studholme K.M., Deutsch D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA. 100:2003;4269-4274.
16. Di Marzo V., Bisogno T., Sugiura T., Melck D., De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J. 331(Pt 1):1998;15-19.
17. Goparaju S.K., Ueda N., Yamaguchi H., Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422:1998;69-73.
18. Lang W., Qin C., Lin S., Khanolkar A.D., Goutopoulos A., Fan P., Abouzid K., Meng Z., Biegel D., Makriyannis A. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J. Med. Chem. 42:1999;896-902.
19. Goparaju S.K., Kurahashi Y., Suzuki H., Ueda N., Yamamoto S. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis(1). Biochim. Biophys Acta. 1441:1999;77-84.
20. Tornqvist H., Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 251:1976;813-819.
21. Mentlein R., Suttorp M., Heymann E. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Arch. Biochem. Biophys. 228:1984;230-246.
22. Goparaju S.K., Ueda N., Taniguchi K., Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57:1999;417-423.
23. Beltramo M., Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport. 11:2000;1231-1235.
24. Lichtman A.H., Hawkins E.G., Griffin G., Cravatt B.F. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther. 302:2002;73-79.
25. Okazaki T., Sagawa N., Okita J.R., Bleasdale J.E., MacDonald P.C., Johnston J.M. Diacylglycerol metabolism and arachidonic acid release in human fetal membranes and decidua vera. J Biol Chem. 256:1981;7316-7321.
26. Prescott S.M., Majerus P.W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl- monoacylglycerol intermediate. J. Biol. Chem. 258:1983;764-769.
27. Rindlisbacher B., Reist M., Zahler P. Diacylglycerol breakdown in plasma membranes of bovine chromaffin cells is a two-step mechanism mediated by a diacylglycerol lipase and a monoacylglycerol lipase. Biochim. Biophys. Acta. 905:1987;349-357.
28. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA. 99:2002;10819-10824.
29. Ng E.W., Aung M.M., Abood M.E., Martin B.R., Razdan R.K. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. J. Med. Chem. 42:1999;1975-1981.
30. 35S ]thio)triphosphate binding Mol. Pharmacol. 44:1993;115-123.
31. 35S ]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum Brain Res. 769:1997;21-28.
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
33. Markey S.P., Dudding T., Wang T.C. Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses. J. Lipid Res. 41:2000;657-662.
34. Deutsch D.G., Omeir R., Arreaza G., Salehani D., Prestwich G.D., Huang Z., Howlett A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 53:1997;255-260.
35. Deutsch D.G., Lin S., Hill W.A., Morse K.L., Salehani D., Arreaza G., Omeir R.L., Makriyannis A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem. Biophys Res. Commun. 231:1997;217-221.
36. Maurelli S., Bisogno T., De Petrocellis L., Di Luccia A., Marino G., Di Marzo V. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. FEBS Lett. 377:1995;82-86.
37. De Petrocellis L, Melck D, Ueda N, Kurahashi Y, Bisogno T, Yamamoto S, V. DM. Brain and peripheral anandamide amidehydrolase and its inhibition by synthetic arachidonate analogues. In: Sinzinger H, Samuelsson B, Vane JR, Paoletti R, Ramwell P, Wong PYK, editors. Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York: Plenum Press, 1998. p. 259-63.
38. Koutek B., Prestwich G.D., Howlett A.C., Chin S.A., Salehani D., Akhavan N., Deutsch D.G. Inhibitors of arachidonoyl ethanolamide hydrolysis. J. Biol. Chem. 269:1994;22937-22940.
39. Bisogno T., Melck D., De Petrocellis L., Bobrov M., Gretskaya N.M., Bezuglov V.V., Sitachitta N., Gerwick W.H., Di Marzo V. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem. Biophys Res. Commun. 248:1998;515-522.
40. Boger D.L., Sato H., Lerner A.E., Hedrick M.P., Fecik R.A., Miyauchi H., Wilkie G.D., Austin B.J., Patricelli M.P., Cravatt B.F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. USA. 97:2000;5044-5049.
41. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9:2003;76-81.
42. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
43. Karlsson M., Contreras J.A., Hellman U., Tornqvist H., Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272:1997;27218-27223.
44. Hillard C.J., Wilkison D.M., Edgemond W.S., Campbell W.B. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys Acta. 1257:1995;249-256.
45. Thomas E.A., Cravatt B.F., Danielson P.E., Gilula N.B., Sutcliffe J.G. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J. Neurosci. Res. 50:1997;1047-1052.
46. Egertova M., Giang D.K., Cravatt B.F., Elphick M.R. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. Lond. B. Biol. Sci. 265:1998;2081-2085.
47. Desarnaud F., Cadas H., Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270:1995;6030-6035.
48. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA. 98:2001;3662-3665.
49. Fezza F., Bisogno T., Minassi A., Appendino G., Mechoulam R., Di Marzo V. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett. 513:2002;294-298.
50. Oka S., Tsuchie A., Tokumura A., Muramatsu M., Suhara Y., Takayama H., Waku K., Sugiura T. Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J. Neurochem. 85:2003;1374-1381.